Alembic Pharmaceuticals Ltd (APLLTD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The companys active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antibacterial, cardiovascular, gynecological, cough and cold, gastroenterological, ophthalmological, anti-diabetic, orthopedic, urology, antihistamine, dermatological and herbal nutraceuticals. APL provides generic formulations such as anti-allergic, anthelmintic, antimicrobials, antiulcerants, nutritional and vitamin preparations, and others speciality products. The company has its research centres and manufacturing facilities in Vadodara, Gujarat and Baddi. APL is headquartered in Vadodara, Gujarat, India.

Alembic Pharmaceuticals Ltd (APLLTD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Alembic Pharma to Form Joint Venture with Orbicular Pharma 13
TG Therapeutics Enters Into Agreement With Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 14
Licensing Agreements 16
Novartis Enters into Licensing Agreement with Rhizen Pharma 16
TG Therapeutics Exercises Option for Licensing Agreement with Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 17
Ranbaxy Pharma Enters Into Licensing Agreement With Alembic Pharma For Desvenlafaxine Base Extended-Release Tablets 19
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 20
Debt Offering 21
Alembic Pharma to Raise up to USD41.5 Million in Private Placement of Debentures 21
Asset Transactions 22
Alembic Pharma Sells its Formulations Manufacturing Facility to Scott-Edil Pharmacia 22
Acquisition 23
Alembic Pharma Acquires Orit Labs 23
Alembic Pharma to Acquire 49% Stake in Adwiya Mami 24
Alembic Pharmaceuticals Ltd - Key Competitors 25
Alembic Pharmaceuticals Ltd - Key Employees 26
Alembic Pharmaceuticals Ltd - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Financial Announcements 29
Jul 20, 2017: Alembic Pharmaceuticals: QI Net Revenue at Rs 648 Crores, Net Profit at Rs 65 Crores 29
May 03, 2017: Alembic Pharmaceuticals: Q4 Net Revenue grew 18% to Rs 740 Crores, Net Profit at Rs 94 cr 31
Jan 25, 2017: Alembic Pharmaceuticals: Q3 Net Profit at Rs 86 cr, Net Revenues at Rs 776 cr 32
Legal and Regulatory 33
Jun 15, 2018: Alembic Pharmaceuticals Receives Establishment Inspection Report For Its Formulation Facility At Panelav 33
May 18, 2018: Alembic Pharmaceuticals Provides Update on US FDA Inspection At its API Facility At Karkhadi 34
Apr 24, 2018: Alembic Pharmaceuticals: Update on Successful US FDA Inspection API Facility at Panelav 35
Mar 21, 2018: USFDA Inspection Formulation Facility at Panelav 36
Aug 31, 2017: Alembic Pharmaceuticals Receives EU GMP Certificate For Its Formulation Facility At Panelav 37
Mar 10, 2017: Alembic Pharmaceuticals Announces US FDA Inspection at Baroda Facility 38
Government and Public Interest 39
Apr 17, 2017: Successful US FDA Inspection at Alembic Pharmaceuticals Bioequivalence Facility at Baroda 39
Other Significant Developments 40
Aug 18, 2017: Alembic Pharmaceuticals: Disruption in plant operations at Algerian JV 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List Of Tables


Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Alembic Pharma to Form Joint Venture with Orbicular Pharma 13
TG Therapeutics Enters Into Agreement With Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 14
Novartis Enters into Licensing Agreement with Rhizen Pharma 16
TG Therapeutics Exercises Option for Licensing Agreement with Rhizen Pharma To Develop PI3K Delta Inhibitor, TGR-1202 17
Ranbaxy Pharma Enters Into Licensing Agreement With Alembic Pharma For Desvenlafaxine Base Extended-Release Tablets 19
Accu-Break Pharma Enters Into Licensing Agreement With Alembic Pharma To Develop Novel Pharma Products 20
Alembic Pharma to Raise up to USD41.5 Million in Private Placement of Debentures 21
Alembic Pharma Sells its Formulations Manufacturing Facility to Scott-Edil Pharmacia 22
Alembic Pharma Acquires Orit Labs 23
Alembic Pharma to Acquire 49% Stake in Adwiya Mami 24
Alembic Pharmaceuticals Ltd, Key Competitors 25
Alembic Pharmaceuticals Ltd, Key Employees 26
Alembic Pharmaceuticals Ltd, Other Locations 27
Alembic Pharmaceuticals Ltd, Subsidiaries 27

List Of Figures


Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alembic Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alembic Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 11

Alembic Pharmaceuticals Ltd (APLLTD) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The companys active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded

USD 250 View Report

Alembic Pharmaceuticals Limited Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Alembic Pharmaceuticals Limited Company Profile is a detailed strategic and analytical report on Alembic Pharmaceuticals Limited. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review

NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Paradigm Biopharmaceuticals Ltd (PAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paradigm Biopharmaceuticals Ltd (Paradigm Biopharma) is a biopharmaceutical company. The company focused on research and development of therapeutic products for human use. It offers pentosan polysulphate sodium (PPS) drugs for

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available